LUCI DAVID P (President and CEO) purchased 4.7% of their position (49.26K shares) of ACURX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $50.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/8/2025ACC: 0001104659-25-002052
DirectorOfficer10% Owner· President and CEO
Since Jun 2021
+98.52K
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
98.52K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+49.26K
Price / share
$1.01
Trade value
$50K
% of position
4.7%
1/6/2025
1.05M→1.10M
Total
Net shares
+49.26K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2025 | P · Purchase | +49.26K | $1.01 | $50K | 4.7% | 1.05M | 1.10M |
| Total | +49.26K | $50K | ||||||
Derivative Transactions1
Warrants for Common Stock
Direct
Converts to
Common Stock
49.26K shares
Shares
+49.26K
Strike price
0.90
Held after
49.26K
Exercisable
—
1/6/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants for Common Stock Direct | Common Stock49.26K shares | 1/6/2025 | P · Purchase | +49.26K | 0.90 | — | 49.26K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned35K
Common Stock
IndirectShares owned15.08K
Total
50.08K indirect50.08K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 35K | Indirect |
| Common Stock | 15.08K | Indirect |
| Total | 50.08K | 50.08K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported